Welcome to our dedicated page for Greenlane Holdings news (Ticker: GNLN), a resource for investors and traders seeking the latest updates and insights on Greenlane Holdings stock.
Greenlane Holdings, Inc. (Nasdaq: GNLN) generates news across two distinct but connected areas: its long-standing role as a global seller of premium cannabis accessories and related products, and its more recent focus as a Berachain-focused digital asset treasury company. Company press releases and SEC filings show that Greenlane issues frequent updates on its operating performance, strategic initiatives, and capital markets activity.
On this page, readers can follow Greenlane’s announcements regarding its distribution business, including developments in premium smoking accessories, vape devices, lifestyle products, child-resistant packaging, and specialty vaporization products. The company has reported initiatives such as restructuring its sales organization, entering and renewing distribution agreements, and expanding into harm reduction offerings like fentanyl and drink spike detection test strips through its wholesale and e-commerce platforms.
Greenlane’s news flow also reflects its transition into the digital asset space. In 2025, the company announced a Berachain cryptocurrency treasury strategy built around the BERA token, along with a large private placement involving cash, stablecoins, and BERA. Subsequent releases have provided updates on BERA holdings, staking activity, and the formation of a Digital Assets Committee and a Chief Investment Officer role to oversee this strategy.
Investors and observers can expect coverage of quarterly and annual financial results, reverse stock split actions related to Nasdaq listing requirements, board and executive appointments, and ongoing disclosures about the company’s Berachain-focused treasury operations. For those tracking GNLN, this news feed offers a centralized view of Greenlane’s progress as it balances its legacy distribution operations with its evolving digital asset treasury model.
Greenlane Holdings (NASDAQ:GNLN) has entered into a distribution agreement with Greentank Technologies to become a major distributor of Greentank's products in the United States. The partnership will include distribution of Greentank's full assortment of cartridges and vaporizers, including their innovative designs.
Greentank, winner of the Golden Leaf Award for "Most Promising Innovation" in 2024, has successfully launched over 500+ vape brands across the US and Canada. The company's breakthrough Quantum Chip™ technology and Quantum Vape™ products focus on precision, safety, and performance in vaping experiences. Notably, Greentank is the only vape manufacturer with a Health Canada Research license and operates its own semi-automated chip manufacturing and R&D facility.
Greenlane Holdings (Nasdaq: GNLN) has announced its integration with Mainstem's B2B procurement marketplace platform, a strategic move to enhance its distribution capabilities and supply chain management. The platform, which has fulfilled over 50,000 orders across legal recreational states and Puerto Rico, will allow multi-state and brick-and-mortar retailers to create customized catalogs of Greenlane products.
The collaboration provides Greenlane with enhanced tools for demand planning and automatic inventory replenishment, along with access to valuable consumer and product trend data. The integration aims to strengthen customer accessibility, improve supply chain coordination, and enhance inventory management efficiency.
CEO Barbara Sher emphasized that this technological implementation aligns with Greenlane's strategy to deliver quality cannabis and wellness products while providing value to customers. The company expects this partnership to expand market access and strengthen operational processes.
Greenlane Holdings (NASDAQ:GNLN) reported its Q4 and full-year 2024 financial results, showing significant changes from its 2023 restructuring. Net sales decreased to $13.3 million from $65.4 million in 2023, primarily due to transitioning from gross sales to a commission structure in packaging and industrial vaping products.
Key financial highlights include:
- Gross margin improved to 47.3% from 27.3% in 2023
- Operating loss improved by $14.3 million to $11.7 million
- Achieved 57.7% reduction in salaries and benefits
- 59.9% decrease in G&A expenses
Post Q4 developments include a $25 million private placement at $1.19 per Common Unit, elimination of material debt obligations, and new distribution agreements with Green Gruff USA and Cannabis Creative Group.
Greenlane Holdings (NASDAQ:GNLN), a leading global seller of premium cannabis accessories, has appointed Cannabis Creative Group as its new digital marketing agency. The Boston-based agency, a division of CHAMP Digital, will spearhead integrated digital marketing and new media initiatives to drive revenue and growth.
CEO Barbara Sher emphasized that this partnership comes as Greenlane is retooling its business strategy, with plans to roll out a new B2B product strategy deeply integrated with marketing efforts. Cannabis Creative Group, recognized as one of the top cannabis digital marketing agencies in the U.S. by Strain Insider, brings expertise in full-funnel planning and omnichannel media solutions.
The agency serves clients across North America, Mexico, and Europe, and has received multiple Hermes Creative Awards for E-commerce, Web Design, Web Development, Digital Advertising, and Creative Design. Their experience spans various industries including cannabis, food & beverage, boating, jewelry, and travel/tourism.
Greenlane Holdings (NASDAQ:GNLN) has secured a $25.0 million private placement offering priced at-the-market, with Aegis Capital Corp. serving as the exclusive placement agent. The transaction was announced on February 20, 2025.
Greenlane Holdings (NASDAQ:GNLN) has closed a $25.0 million private placement of Common Stock and investor warrants at $1.19 per Common Unit. The offering included 21,008,405 Common Units, each comprising one share of Common Stock or Pre-Funded Warrant, plus two types of warrants: Series A and Series B.
The Series A Warrants have an exercise price of $1.4875 with a 5-year term, while Series B Warrants are priced at $2.975 with a 2.5-year term. Both warrant series will be exercisable following stockholder approval.
The company plans to use the proceeds for debt repayment, general corporate purposes, and working capital. Aegis Capital Corp. served as the exclusive placement agent for this private transaction, which closed on February 19, 2025.
Greenlane Holdings (NASDAQ:GNLN) has secured definitive agreements with institutional investors for a $25.0 million private placement priced at $1.19 per Common Unit. The offering includes Common Units consisting of one share of Common Stock or Pre-Funded Warrant, plus two types of warrants: Series A warrants with an exercise price of $1.4875 (5-year term) and Series B warrants with an exercise price of $2.975 (2.5-year term).
The transaction is expected to close around February 19, 2025. The company plans to use the proceeds for repaying existing debt, general corporate purposes, and working capital. Aegis Capital Corp. serves as the exclusive placement agent. The securities are being sold in a private placement to accredited investors and will require registration with the SEC for resale.
Greenlane Holdings (NASDAQ:GNLN) has regained full compliance with Nasdaq Listing Rule 5605(c)(2) following the appointment of Michael C. Howe as an independent director and audit committee member on December 31, 2024. This appointment resolves all previously announced deficiencies in Nasdaq continued listing requirements.
Howe brings over 40 years of consumer and healthcare experience, having held management positions at Procter & Gamble and PepsiCo, and CEO roles at Arby's and MinuteClinic. His notable achievement includes expanding MinuteClinic from 19 locations to over 530 during his tenure, culminating in its acquisition by CVS in 2006. Howe's expertise spans commercial strategy, operations, and business development, with a focus on branding, marketing, and organizational development.
Greenlane Holdings (Nasdaq: GNLN) has signed an exclusive U.S. distribution agreement with Green Gruff USA to enter the canine CBD supplements market. Green Gruff offers veterinarian-approved organic CBD-infused supplements and treats for dogs, manufactured in the U.S.
The products, developed by pet industry professionals and veterinarians, include non-GMO, pesticide-free, broad-spectrum hemp leaf supplements. These will be available through Greenlane's online retail platforms (vapor.com, puffitup.com, higherstandards.com) and wholesale portal.
Green Gruff currently serves over 1,000 dispensaries, and this partnership aims to expand their reach while diversifying Greenlane's product offerings. The agreement positions Greenlane to capitalize on the growing U.S. demand for legal CBD pet products, potentially generating incremental revenue.